Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Get quotas from patients

<< Previous

Bullboard Posts

Next >>

Post by Ekenbulletson Jun 02, 2021 4:29am

294 Views

Post# 33309103

Get quotas from patients

Being active in the Diabetes community in Europe I know how good news related to diabete care just takes of and flies all over the different forums and facebook groups.

Numbers like Hba1c, Time in Range, Standard deviation (becoming more and more important in patient follow ups) and % of time under 4mmol are important but what could help news fly is quotas/interviews with patient/s furtherst in the study. If they could describe that this has been lifechanging it would make such a ripple in the dia comnunity. I hope they will make that as soon as possible.

<< Previous

Bullboard Posts

Next >>

Three business reasons companies need to recycle e-waste